Di Lorenzo, Giuseppe
 Distribuzione geografica
Continente #
AS - Asia 1.018
SA - Sud America 689
NA - Nord America 363
EU - Europa 189
AF - Africa 55
OC - Oceania 3
Totale 2.317
Nazione #
SG - Singapore 633
BR - Brasile 601
US - Stati Uniti d'America 273
HK - Hong Kong 102
IT - Italia 79
VN - Vietnam 77
MX - Messico 50
BD - Bangladesh 31
AR - Argentina 30
CN - Cina 26
GB - Regno Unito 26
IN - India 24
CA - Canada 21
IQ - Iraq 19
NL - Olanda 18
SA - Arabia Saudita 18
ID - Indonesia 15
TR - Turchia 15
DE - Germania 14
VE - Venezuela 14
UZ - Uzbekistan 13
ZA - Sudafrica 13
EC - Ecuador 12
EG - Egitto 12
UA - Ucraina 12
MA - Marocco 9
CO - Colombia 8
PK - Pakistan 8
PY - Paraguay 8
RU - Federazione Russa 8
AE - Emirati Arabi Uniti 7
FR - Francia 6
JO - Giordania 6
KE - Kenya 6
UY - Uruguay 6
BO - Bolivia 5
ES - Italia 5
ET - Etiopia 5
TN - Tunisia 5
CH - Svizzera 4
JM - Giamaica 4
OM - Oman 4
AL - Albania 3
AU - Australia 3
BB - Barbados 3
LB - Libano 3
NP - Nepal 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CL - Cile 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
AT - Austria 1
BS - Bahamas 1
BZ - Belize 1
CM - Camerun 1
CY - Cipro 1
CZ - Repubblica Ceca 1
FI - Finlandia 1
GA - Gabon 1
HN - Honduras 1
HT - Haiti 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
KY - Cayman, isole 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MR - Mauritania 1
RS - Serbia 1
SE - Svezia 1
YE - Yemen 1
Totale 2.317
Città #
Singapore 424
Hong Kong 87
Mexico City 41
São Paulo 40
Ho Chi Minh City 33
Rome 28
Beijing 22
Hanoi 16
Naples 14
Rio de Janeiro 14
Brasília 13
Belo Horizonte 12
Chicago 12
Tashkent 12
Campinas 11
Salvador 9
Dhaka 8
Baghdad 7
Boardman 7
Curitiba 7
Goiânia 7
New York 7
Porto Alegre 7
Amman 6
Contagem 6
Jeddah 6
Belford Roxo 5
Cairo 5
Cleveland 5
Istanbul 5
Johannesburg 5
João Pessoa 5
Milan 5
Montevideo 5
Riyadh 5
Santo André 5
Bragança Paulista 4
Cape Town 4
Casablanca 4
Charlotte 4
Dubai 4
Fortaleza 4
Guarulhos 4
Guayaquil 4
Haiphong 4
Juiz de Fora 4
Jundiaí 4
Lahore 4
Nairobi 4
Nepean 4
Philadelphia 4
Praia Grande 4
Ribeirão Preto 4
Sete Lagoas 4
Sorocaba 4
Taubaté 4
Toronto 4
Uberlândia 4
Vancouver 4
Addis Ababa 3
Anaheim 3
Ankara 3
Atlanta 3
Balneário Camboriú 3
Baltimore 3
Barquisimeto 3
Biên Hòa 3
Blumenau 3
Bridgetown 3
Buenos Aires 3
Dallas 3
Dammam 3
Delhi 3
Governador Valadares 3
Indianapolis 3
Irecê 3
Itaquaquecetuba 3
Joinville 3
La Paz 3
Las Vegas 3
Macapá 3
Maracaibo 3
Mariana 3
Maricá 3
Mauá 3
Muscat 3
Nova Iguaçu 3
Orlando 3
Pelotas 3
Quito 3
Recife 3
San Lorenzello 3
Santa Cruz 3
Santa Luzia 3
Santa Maria 3
Santana do Livramento 3
Sobral 3
São Gonçalo 3
São José dos Campos 3
São Vicente 3
Totale 1.121
Nome #
Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients 41
Clinical characteristics of metastatic prostate cancer patients infected with COVID-19 in South Italy 25
A case of renal melanoma metastasis: Description of clinico-pathological features 20
Validation of Psychometric Tools for Assessing Fatigue, Mood, and Sleep Quality: Application in the PREVES-STOP Study. 18
Development and Validation of the PREVESMED Questionnaire: A Comprehensive Tool for Assessing Adherence to a Mediterranean Lifestyle 16
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers 15
An evolving role for immunotherapy in metastatic RCC 14
Prostate Cancer Detection in the "Grey Area" of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun's Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3 14
Instant messaging in cancer care 14
Impact of Dietary Supplements on Clinical Outcomes and 2 Quality of Life in Patients with Breast Cancer: A Systematic Review 14
KIDNEY CANCER Overall survival is an unsuitable primary end point 14
Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection 13
Re: Matthew R. Smith, Maha Hussain, Fred Saad, et al. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med. 2022;386:1132–1142 13
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients 13
Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy 13
Predicting early and delayed bleedings in children who undergo adeno-tonsillectomy surgery. Is it really possible? 13
Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study 13
Everolimus as second-line therapy for metastatic renal cell carcinoma: a 'real-life' study 13
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 12
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 12
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial 12
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis 12
PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study 12
Management of AIDS-related Kaposi's sarcoma 12
Docetaxel Rechallenge in a Heavily Pretreated Patient with Castration-Resistant Prostate Cancer 12
Focus on localized laryngeal amyloidosis: Management of five cases 12
Chirurgia conservativa e qualità di vita in pazienti con carcinoma renale localizzato. 12
INCREASED EXPRESSION OF THE AUTOCRINE MOTILITY FACTOR IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS WITH CLEAR CELL – RENAL CELL CARCINOMA 12
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors 12
Efficacy of Sunitinib Rechallenge in Kidney Cancer: Are mTOR Inhibitors Involved or Is It Only a Matter of Time? 12
Adrenalectomy: defining its role in the surgical treatment of renal cell carcinoma. 11
Incidence of fatigue and low dose of corticosteroids in patients receiving systemic treatment: a metanalysis of randomized trials 11
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: A phase II study 11
Optimal management of a patient with recurrent nasopharyngeal carcinoma 11
Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis 11
Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial 11
Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer 11
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: A retrospective Italian survey 11
Combination therapy for metastatic renal cell carcinoma 11
Cisplatin- Versus Non-Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin 11
Kaempferol, myricetin and fisetin in prostate and bladder cancer: a systematic review of literature 11
Medical expulsive treatment of distal-ureteral stones using tamsulosin: A single-center experience 11
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario 11
Kaempferol, myricetin and fisetin in prostate and bladder cancer: A systematic review of the literature 10
Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience 10
The use of tamsulosin in the medical treatment of ureteral calculi: Where do we stand? 10
LOOKING AT THE PROSTATES OF PATIENTS WITH BLADDER CANCER: A THOUGHTFUL EXERCISE 10
Predictors of Residual T1 High Grade on Re- Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer 10
Immunotherapy for the treatment of prostate cancer 10
Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: A multicenter study 10
Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen 10
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond 10
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 10
Gemcitabine Versus Bacille Calmette-Guerin After Initial Bacille Calmette-Guerin Failure in Non-Muscle-Invasive Bladder Cancer A Multicenter Prospective Randomized Trial 10
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 10
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 10
Expression of HECA-452 in parapsoriasis and mycosis fungoides 10
Outcomes associated with first-line PD-1 and PD-L1 inhibitors vs. sunitinib in patients with renal cell cancer with sarcomatoid features: a systematic review and meta-analysis 10
A Challenging Surgical Approach to Locally Advanced Primary Urethral Carcinoma: A Case Report and Literature Review 10
Myrtucommulone Production by a Strain of Neofusicoccum australe Endophytic in Myrtle. 10
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study 10
A Prognostic Model for Patients With Metastatic Renal Cell Cancer: What's New? 10
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 10
Synergistic Combination of Quercetin and Mafosfamide in the Treatment of Bladder Cancer Cells 10
The role of immunotherapy in oncology 10
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 10
An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples (vol 12, pg 1491, 2011) 10
Second-line treatment for renal cell cancer 10
ADVERSE EVENTS 1 OF IMMUNE CHECKPOINT INHIBITORS THERAPYFOR UROLOGIC CANCER PATIENTS IN CLINICAL TRIALS: A COLLABORATIVE SYSTEMATIC REVIEW AND META ANALYSIS 10
READY: Real-world data from an Italian compassionate use program of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC) 10
Dysregulated metabolism: A relevant player in prostate cancer progression and clinical management 10
Nature's hidden gem: quercitrin's promising role in preventing prostate and bladder cancer 10
Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer 10
The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer 10
Activity of platinum-based chemotherapy in advanced prostate cancer patients with and without DNA repair gene aberrations: An International Collaborative Analysis 10
Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a Phase II trial 10
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 9
PCA3 COMPARISON WITH PROSTATE HEALTH INDEX (PHI) IN REPEAT BIOPSY PATIENTS 9
TUMORI UROLOGICI: PROSTATA, RENE E VESCICA 9
Squamous cell carcinoma of the scrotum: A look beyond the chimneystacks 9
Long lasting response to second-line everolimus in kidney cancer. 9
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: a systematic review and meta-analysis 9
Optimal Management of Metastatic Castration-Resistant Prostate Cancer:Highlights from a European Expert Consensus Panel 9
TUMORI UROLOGICI: TUMORI DEL TESTICOLO, PROSTATA, RENE E VESCICA 9
Involvement of growth factor receptors of the epidermal growth factor receptor (EGFR) family in prostate cancer development and in the progression to androgen- independence. 9
Expression of proto-oncogene c-kit in high risk prostate cancer 9
Numerical study of laminar confined impinging slot jets with nanofluids 9
Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immune-oncology (I-O). A real-world study on behalf of Meet-URO group (MeetUro-7b) 9
Real-world experience with cabazitaxel in patients with metastatic castration-resistant prostate cancer: a final, pooled analysis of the compassionate use programme and early access programme 9
Techniques of iconographic documentation [Techniche di documentazione iconografica] 9
New perspectives in the therapy of castration resistant prostate cancer 9
Hypercastration in prostate cancer 9
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy 9
Correlation Between Serum Prostate-specific Antigen and Cancer Volume in Prostate Glands of Different Sizes EDITORIAL COMMENT 9
Thermal and fluid dynamic behaviors of confined laminar impinging slot jets with nanofluids 9
Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era 9
Computed-Tomography-Structured Reporting in Middle Ear Opacification: Surgical Results and Clinical Considerations From a Large Retrospective Analysis 9
Dynamic sentinel node biopsy in clinically node-negative penile cancer versus radical inguinal lymphadenectomy: a comparative study 9
A complete response with rituximab in metastatic diffuse large B-cell lymphoma of the testis: case report 9
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results 9
Totale 1.129
Categoria #
all - tutte 16.552
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.552


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.165 0 0 0 28 338 19 114 372 101 60 553 580
2025/2026515 266 27 222 0 0 0 0 0 0 0 0 0
Totale 2.680